Skip to main content

Table 2 Comparison of metformin-associated lactic acidosis and very severe lactic acidosis of other origin (pH < 7.0)

From: Outcome of severe lactic acidosis associated with metformin accumulation

 

All patients with pH < 7.0 (n= 41)

MALA (n= 10)

LAOO (n= 31)

Age, years

64 ± 13

66 ± 9

64 ± 14

Male gender

19 (46%)

4 (40%)

15 (48%)

SAPS II

84 ± 18

88 ± 23

83 ± 16

SOFA score

14.0 ± 2.9

14.3 ± 1.4

13.8 ± 3.4

   Respiratory

2.7 ± 1.0

2.7 ± 0.9

2.8 ± 1.0

   Renal

3.0 ± 1.1

4.0 ± 0.0

2.6 ± 1.1a

   Hepatic

0.5 ± 0.8

0.3 ± 0.7

0.6 ± 0.9

   Cardiovascular

3.6 ± 1.2

4.0 ± 0.0

3.4 ± 1.4

   Hematologic

0.8 ± 1.1

0.5 ± 0.8

0.9 ± 1.2

   Neurologic

3.3 ± 1.2

2.8 ± 1.5

3.5 ± 1.1

Lactate, mmol/L

18.1 ± 6.5

18.7 ± 5.3

17.9 ± 6.9

pH

6.83 ± 0.12

6.75 ± 0.13

6.86 ± 0.11a

Bicarbonate, mmol/L

9.0 ± 4.8

4.4 ± 2.4

10.5 ± 4.5a

Creatinine, μmol/L

529 ± 392

796 ± 324

195 ± 91a

Survival

4 (10%)

5 (50%)

0 (0%)a

  1. Values are presented as mean ± standard deviation or as number (percentage). Comparison with metformin-associated lactic acidosis (MALA): aP < 0.01. LAOO, lactic acidosis of other origin; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment.